Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated with sorafenib

Ila Tamaskar, Ronald M. Bukowski, Paul Elson, +6

Annals of Oncology

UrologyGenitourinary CancerMedicineThyroid DiseaseThyroid Hormone +2

A 2weeks on and 1week off schedule of sunitinib is associated with decreased toxicity in metastatic renal cell carcinoma

Yana G. Najjar, Kriti Mittal, Paul Elson, +4

European Journal of Cancer

UrologyOncologyGenitourinary CancerMedicineDecreased Toxicity +2

Sunitinib and sorafenib in metastatic renal cell carcinoma patients with renal insufficiency

Gazala Khan, Ali Golshayan, Paul Elson, +4

Annals of Oncology

UrologyRenal InsufficiencyGenitourinary CancerMedicineCancer Treatment +3

Temsirolimus in VEGF-refractory metastatic renal cell carcinoma

Mary J. MacKenzie, Brian I. Rini, Paul Elson, +5

Annals of Oncology

Cancer GrowthUrologyKidney ResearchGenitourinary Cancer

Thyroid function tests (TFTs) abnormalities in patients (pts) with metastatic renal cell carcinoma (mRCC) treated with sunitinib

Philip Shaheen, Ila Tamaskar, R. N. Salas, +5

Journal of Clinical Oncology

Tfts AssessmentRenal PathologyPharmacotherapyEndocrine OncologyOncology +16

Phase I study using continuous intravenous (CI) KOS-862 (Epothilone D) in patients with solid tumors

Kyle D. Holen, Samira Syed, Alison L. Hannah, +7

Journal of Clinical Oncology

Solid TumorsPharmacotherapyMetronomic ChemotherapyPharmacodynamic ModelingPre-clinical Pharmacology +19

Antitumor effects of sorafenib and sunitinib in patients (pts) with metastatic renal cell carcinoma (mRCC) who had prior therapy with anti-angiogenic agents

Ila Tamaskar, Philip Shaheen, L. Wood, +6

Journal of Clinical Oncology

Anti-angiogenic AgentsImmunotherapeuticsPharmacotherapyPre-clinical PharmacologyGenitourinary Cancer +14

Approaches to managing carboplatin-induced thrombocytopenia: focus on the role of amifostine.

G. Thomas Budd, Ram Ganapathi, L. Wood, +3

PubMed

Phase I and II trials of subcutaneously administered rIL-2, interferon alfa-2a, and fluorouracil in patients with metastatic renal carcinoma

Thomas Olencki, David M. Peereboom, L. Wood, +6

Journal of Cancer Research and Clinical Oncology

UrologyGenitourinary CancerMedicinePharmacologyMetastatic Renal Carcinoma +5

Gene Modulatory Effects, Pharmacokinetics, and Clinical Tolerance of Interferon-α1b: A Second Member of the Interferon-α Family

P. Masci, Thomas Olencki, L. Wood, +7

Clinical Pharmacology & Therapeutics

GeneticsImmunologyPathologyCell DeathImmunologic Mechanism +18